ULS · XBRL financial data
UL Solutions financial statements, every fiscal year
The same tables from 2 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (ULS's year ends in late December)
| In millions of dollars | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|
| Revenue from contracts with customers | 2,870 | 3,053 |
| Cost of revenue | 1,477 | 1,543 |
| Selling, general and administrative | 931 | 953 |
| Operating income (loss) | 462 | 522 |
| Interest expense | 55 | 41 |
| Other income (expense) | (2) | (1) |
| Income tax expense (benefit) | 70 | 125 |
| Net income (loss) | 326 | 325 |
| Earnings per share, basic USD per share | 1.63 | 1.62 |
| Earnings per share, diluted USD per share | 1.62 | 1.60 |
| Weighted average shares, basic millions of shares | 200 | 201 |
| Weighted average shares, diluted millions of shares | 201 | 203 |
Balance sheet
CSVFiscal years (ULS's year ends in late December)
| In millions of dollars | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|
| Cash and cash equivalents | 298 | 295 |
| Accounts receivable | 380 | 422 |
| Total current assets | 921 | 1,000 |
| Property and equipment, net | 631 | 699 |
| Right-of-use asset | 186 | 179 |
| Goodwill | 633 | 656 |
| Total assets | 2,800 | 2,921 |
| Accounts payable | 182 | 183 |
| Current portion of long-term debt | 50 | 0 |
| Total current liabilities | 740 | 760 |
| Long-term debt | 692 | 491 |
| Lease liability, non-current | 155 | 149 |
| Total liabilities | 1,869 | 1,627 |
| Retained earnings | 250 | 470 |
| Total stockholders' equity | 904 | 1,262 |
| Total liabilities and equity | 2,800 | 2,921 |
| Common shares outstanding (cover page) millions of shares | 200 | 201 |
Cash flows
CSVFiscal years (ULS's year ends in late December)
| In millions of dollars | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|
| Net income (loss) | 326 | 325 |
| Stock-based compensation | 23 | 47 |
| Depreciation and amortization | 172 | 188 |
| Net cash from operating activities | 524 | 600 |
| Purchases of property and equipment | 237 | 197 |
| Net cash from investing activities | (234) | (204) |
| Dividends paid | 100 | 104 |
| Proceeds from long-term debt | 181 | 792 |
| Repayments of long-term debt | 346 | 1,045 |
| Net cash from financing activities | (284) | (396) |
| Net change in cash | (17) | (3) |
Compare with peers
SIC 8734 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8734 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Quarter |
|---|---|---|---|---|---|
| UL Solutions | 1,016 | 823 | 215* | not reported | 10-QSep 30, 2026 |
| Medpace Holdings | 705 | 716 | 217* | 28.0M | 10-QSep 30, 2026 |
| Charles River Laboratories International | 200 | 983 | 254* | 47.9M | 10-QSep 26, 2026 |
| Incyte | 3,276 | 1,557 | (675)* | 203.8M | 10-QSep 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.
Data on this page was fetched . The filing on SEC.gov is the record.